SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-010181
Filing Date
2024-07-25
Accepted
2024-07-25 16:10:34
Documents
74
Period of Report
2024-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q knsa-20240630x10q.htm   iXBRL 10-Q 2384172
2 EX-10.12 knsa-20240630xex10d12.htm EX-10.12 370477
3 EX-10.13 knsa-20240630xex10d13.htm EX-10.13 80714
4 EX-31.1 knsa-20240630xex31d1.htm EX-31.1 11343
5 EX-31.2 knsa-20240630xex31d2.htm EX-31.2 10499
6 EX-32.1 knsa-20240630xex32d1.htm EX-32.1 6305
7 EX-32.2 knsa-20240630xex32d2.htm EX-32.2 6279
  Complete submission text file 0001558370-24-010181.txt   9345429

Data Files

Seq Description Document Type Size
8 EX-101.SCH knsa-20240630.xsd EX-101.SCH 54220
9 EX-101.CAL knsa-20240630_cal.xml EX-101.CAL 52177
10 EX-101.DEF knsa-20240630_def.xml EX-101.DEF 284403
11 EX-101.LAB knsa-20240630_lab.xml EX-101.LAB 471649
12 EX-101.PRE knsa-20240630_pre.xml EX-101.PRE 389856
77 EXTRACTED XBRL INSTANCE DOCUMENT knsa-20240630x10q_htm.xml XML 1476880
Mailing Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ
Business Address 23 OLD BOND STREET, FLOOR 3 LONDON X0 WIS 4PZ 7814319100
Kiniksa Pharmaceuticals International, plc (Filer) CIK: 0001730430 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38492 | Film No.: 241142151
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)